All Updates

All Updates

icon
Filter
Funding
NOWDiagnostics raises USD 22.5 million in Series B funding to accelerate commercialization of at-home diagnostic tests
Precision Medicine
Jul 9, 2024
This week:
Partnerships
Qualcomm and Google partner to develop AI-driven automotive solutions
Auto Tech
Yesterday
Product updates
Meta AI releases LayerSkip to accelerate inference in LLMs
Generative AI Infrastructure
Yesterday
Funding
Freeform secures funding from NVIDIA's NVentures
Additive Manufacturing
Oct 22, 2024
Product updates
Flexxbotics announces compatibility with LMI Technologies for quality inspection
Smart Factory
Oct 22, 2024
Funding
Oxla raises USD 11 million in seed funding to drive commercialization
Data Infrastructure & Analytics
Oct 22, 2024
Product updates
Cohesity enhances Gaia, its AI assistant, with visual data exploration and expanded data sources
Data Infrastructure & Analytics
Oct 22, 2024
Product updates
Finzly launches FedNow service through BankOS platform in AWS marketplace
FinTech Infrastructure
Oct 22, 2024
Product updates
Runway launches Act-One for AI facial expression motion capture
Generative AI Applications
Oct 22, 2024
Product updates
Ideogram launches Canvas for image manipulation and generation
Generative AI Applications
Oct 22, 2024
Partnerships
UiPath partners with Inflection AI to integrate AI solutions for enterprises
Generative AI Applications
Oct 22, 2024
Precision Medicine

Precision Medicine

Jul 9, 2024

NOWDiagnostics raises USD 22.5 million in Series B funding to accelerate commercialization of at-home diagnostic tests

Funding

  • NOWDiagnostics has raised USD 22.5 million in a Series B funding round led by DigitalDx Ventures, with participation from Labcorp Venture Fund and Kompass Kapital Management, among others.

  • The funds are planned to be used for commercializing its at-home diagnostic tests, developing new diagnostic technologies, recruiting purposes, and expanding its clinical research pipeline, which includes over 30 diagnostic tests. 

  • NOWDiagnostics develops and manufactures rapid diagnostic tests for over-the-counter (OTC) and point-of-care (POC) settings. The company uses its proprietary "Touch to Test" technology to deliver rapid results using a small amount of capillary blood or saliva. The company's product line includes tests for infectious diseases, cardiac markers, and women’s health.​

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.